Product information

From Health Canada

Current status:

Marketed

Current status date:

2014-02-22

Original market date: See footnote 1

2010-11-15

Product name:

TEVA-LACTULOSE

DIN:

02331551 Electronic product monograph is not available

Company:

TEVA CANADA LIMITED
30 Novopharm Court
Toronto
Ontario
Canada M1B 2K9

Class:

Human

Dosage form(s):

Solution

Route(s) of administration:

Oral

Number of active ingredient(s):

1

Schedule(s):

OTC

 

American Hospital Formulary Service (AHFS): See footnote 3

40:10.00 

Anatomical Therapeutic Chemical (ATC): See footnote 4

A06AD11 LACTULOSE

Active ingredient group (AIG) number:See footnote5

0113020001

List of active ingredient(s)
Active ingredient(s) Strength
LACTULOSE 667 MG / ML
Version 4.0.2
Date modified: